Debevoise Advises Hamilton Lane in the Acquisition of a Significant Equity Interest in Cosette

17 July 2024

Debevoise & Plimpton LLP is advising Hamilton Lane (NASDAQ: HLNE) in the acquisition of a significant equity interest in Cosette Pharmaceuticals from Avista and its co-investors through funds managed by Hamilton Lane. For more information, please see the company’s press release.

The Debevoise team is led by M&A partner Kevin Schmidt and counsel John Love and includes counsel Kim Le and Keith Slattery and associate Rekha Korlipara, and antitrust partner Tim Cornell and international counsel Anne-Mette Heemsoth and FDA regulatory counsel Melissa Runsten.